Pacific Biosciences of California Inc (NASDAQ: PACB) is -3.28% lower on its value in year-to-date trading and has touched a low of $1.16 and a high of $6.09 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The PACB stock was last observed hovering at around $1.87 in the last trading session, with the day’s loss setting it -0.1%.
Currently trading at $1.77, the stock is 11.25% and -1.90% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 16.94 million and changing -5.35% at the moment leaves the stock -0.76% off its SMA200. PACB registered -73.46% loss for a year compared to 6-month gain of 13.46%.
The stock witnessed a 7.93% loss in the last 1 month and extending the period to 3 months gives it a -4.58%, and is 33.08% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 19.56% over the week and 11.41% over the month.
Pacific Biosciences of California Inc (PACB) has around 796 employees, a market worth around $484.73M and $154.01M in sales. Profit margin for the company is -200.40%. Distance from 52-week low is 52.59% and -70.94% from its 52-week high. The company has generated returns on investments over the last 12 months (-26.15%).
with sales reaching $33.88M over the same period.The EPS is expected to grow by 33.49% this year, but quarterly earnings will post 5.23% year-over-year. Quarterly sales are estimated to shrink -12.71% in year-over-year returns.
The shares outstanding are 273.86M, and float is at 222.62M with Short Float at 27.13%.
The top institutional shareholder in the company is ARK INVESTMENT MANAGEMENT LLC with over 33.21 million shares valued at $45.5 million. The investor’s holdings represent 12.1932 of the PACB Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 26.0 million shares valued at $35.62 million to account for 9.6443 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 23.61 million shares representing 8.7576 and valued at over $32.34 million, while MADRONE ADVISORS, LLC holds 8.5878 of the shares totaling 23.39 million with a market value of $32.05 million.
Pacific Biosciences of California Inc (PACB) Insider Activity
The most recent transaction is an insider sale by Farmer Michele,. SEC filings show that Farmer Michele sold 24,349 shares of the company’s common stock on Feb 18 ’25 at a price of $1.88 per share for a total of $45727.0. Following the sale, the insider now owns 0.19 million shares.
Pacific Biosciences of California Inc disclosed in a document filed with the SEC on Feb 18 ’25 that Van Oene Mark sold a total of 100,773 shares of the company’s common stock. The trade occurred on Feb 18 ’25 and was made at $1.88 per share for $0.19 million. Following the transaction, the insider now directly holds 1.5 million shares of the PACB stock.
Still, SEC filings show that on Feb 18 ’25, HENRY CHRISTIAN O disposed off 259,909 shares at an average price of $1.88 for $0.49 million. The insider now directly holds 2,237,854 shares of Pacific Biosciences of California Inc (PACB).
